Leerink Partnrs Reaffirms Outperform Rating for Cartesian Therapeutics (NASDAQ:RNAC)
Related Articles
-
Berenberg Bank Reaffirms “Buy” Rating for Dunelm Group (LON:DNLM)
Dunelm Group (LON:DNLM – Get Free Report)‘s stock had its “buy” rating reaffirmed by Berenberg Bank in a research note issued on Thursday, Marketbeat.com reports. They currently have a GBX 1,410 ($17.55) price target on the stock. Berenberg Bank’s price objective would suggest a potential upside of 44.76% from the company’s previous close. Separately, Jefferies […]
-
Coventry restaurant receives one-star hygiene rating over 'management of food safety'
Dosa Mama in Cheylesmore was inspected by the Food Standards Agency
-
Fed leaves interest rates unchanged amid inflation rate higher than 2% target
May 1 (UPI) — The Federal Reserve Wednesday voted to keep interest rates unchanged, in line with expectations as inflation remains above the central bank’s 2% threshold. The Federal reserve’s Federal Open Market Committee said in a statement that the central bank left interest rates for overnight bank borrowing within a range of 5.25%-5.5%. With CPI inflation at 3.5%, the […] The post Fed leaves interest rates unchanged amid inflation rate higher than 2% target first appeared on Gephardt Daily.